CD8A and neoplasm: In contrast to MISTRG-6 mice, NSG-Quad mice did not improve human NK cell development in the blood, and the frequency of human CD4+ and CD8+ T cells was reduced in the blood and spleen but not in the tumor of NSG-Quad mice.